MindMed to Participate in May Investor Conferences

Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has announced participation in two upcoming investor conferences. The first event is the H.C. Wainwright BioConnect Conference scheduled for May 2, 2023, featuring 1x1 investor meetings. The second event is the RBC Capital Markets Global Healthcare Conference, taking place on May 17, 2023, at 4:35 pm EDT, which will include a fireside chat format. Audio webcasts and replays of the presentations will be available on MindMed’s Investor Resources page for 90 days after each event.

MindMed focuses on developing innovative treatments for brain health disorders targeting neurotransmitter pathways. The company aims to lead in this sector with its pipeline of novel product candidates.

NEW YORK--(BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the Company’s management team will participate in the following investor conferences:

• H.C. Wainwright BioConnect Conference
  • Format: 1x1 Investor Meetings
  • Date: Tuesday, May 2, 2023
• RBC Capital Markets Global Healthcare Conference
  • Format: Fireside Chat
  • Date and Time: Wednesday, May 17 at 4:35 pm EDT
  • Webcast Link: RBC Capital Markets Global Healthcare Conference

Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Resources website for up to 90 days following each event.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005249/en/

For Media & Investor Inquiries, please contact:

Maxim Jacobs, CFA

Vice President, Investor Relations and Corporate Communications

Mind Medicine (MindMed) Inc.

ir@mindmed.co

media@mindmed.co

Source: MindMed

FAQ

What conferences will MNMD participate in May 2023?

MindMed will participate in the H.C. Wainwright BioConnect Conference on May 2, 2023, and the RBC Capital Markets Global Healthcare Conference on May 17, 2023.

What is the date and format of the RBC Capital Markets Global Healthcare Conference?

The RBC Capital Markets Global Healthcare Conference will be on May 17, 2023, at 4:35 pm EDT, featuring a fireside chat.

Where can I find replays of MNMD's conference presentations?

Replays of MindMed's conference presentations can be accessed on their Investor Resources website for 90 days after each event.

What is MindMed's focus as a biopharmaceutical company?

MindMed focuses on developing novel product candidates aimed at treating brain health disorders.

What is the stock symbol for MindMed?

MindMed trades under the stock symbol MNMD on NASDAQ.